ChartRow logo
ChartRow
Stocks and ETFs
ABBV
AbbVie Inc.Stock · Healthcare
$261.07+$10.01 (+3.99%)as of market close, Jul 2, 2026
CompareLLYUNHJNJMRKABTTMO

How AbbVie makes money

Fiscal year

How does AbbVie make money? This Sankey traces every dollar of revenue through the income statement — into cost of revenue, R&D, SG&A, and taxes — and shows what's left as profit. Pick any fiscal year. Straight from SEC filings.

AbbVie Inc. · FY2025 · year ended 2025-12-31
Revenue$61.2BGross profit$43.0B · 70%Cost of revenue$18.2B · 30%Operating income$15.1B · 25%Operating expenses$27.9B · 46%R&D$9.1B · 15%SG&A$14.0B · 23%Other opex$4.8B · 8%Pre-tax income$6.6B · 11%Other expense$8.5B · 14%Net income$4.2B · 7%Income tax$2.4B · 4%

Each fiscal year from SEC filings. Percentages are share of revenue, so the green profit nodes read directly as gross / operating / net margin. Line items a company doesn't break out are derived from their siblings so the flows balance; small residuals show as “Other.” For informational purposes only.